OSCR
Overvalued by 237.7% based on the discounted cash flow analysis.
Market cap | $3.02 Billion |
---|---|
Enterprise Value | $1.09 Billion |
Dividend Yield | $0 (0%) |
Earnings per Share | $0.11 |
Beta | 1.75 |
Outstanding Shares | 251,279,000 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 28.12 |
---|---|
PEG | 50.94 |
Price to Sales | 0.39 |
Price to Book Ratio | 3.08 |
Enterprise Value to Revenue | 0.11 |
Enterprise Value to EBIT | 12.79 |
Enterprise Value to Net Income | 8 |
Total Debt to Enterprise | 0.28 |
Debt to Equity | 0.22 |
No data
No data
Headquartered in New York City, Oscar has been challenging the health care s\stem's status quo since our founding in 2012. The compan\Ŗs member-ırst philosoph\ and innovative approach to care has earned us the trust of approxim...